The Global Health Body Sounds Alert Over Critical Scarcity of Weight-Loss Medications
Under a tenth of individuals that would benefit from GLP-1 drugs such as Wegovy are able to get them, warns the World Health Organization as it publishes its inaugural advice on the therapies.
Given over a billion people worldwide now classified as obese, it is calling for increased and just availability to these injectable treatments.
Per estimates, more than two billion could be living with obesity by 2030 if no action is taken.
"Our latest guidelines affirms that excess weight is a long-term condition that can be addressed with comprehensive and continuous treatment," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and supply-chain constraints are key barriers to universal access to the jabs that can assist patients in reducing significant body mass, notes the organization.
Weight-Loss Drug Scarcity
Even in the present most optimistic case, the manufacturing of such drugs could only cover around 100 million people – fewer than 10% of the global need, according to the WHO.
The recommendation urges countries and companies to expand access, by measures such as licensing agreements.
A patent on a key compound – the primary ingredient of Novo Nordisk's Wegovy – is scheduled to end in several countries in 2026.
The Way Weight-Loss Injections Operate
The injections replicate a body's own hormone to reduce digestion speed, curb appetite and increase satiety so individuals reduce food intake.
Patients usually begin shedding pounds within a few weeks of starting on the regular doses.
Studies indicates people may see weight return within a year of halting the treatment, because their usual hunger resume.
Being above a healthy weight raises your likelihood for developing health problems, including type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.
Obesity affects people in every country and was associated with over three and a half million deaths worldwide in 2024, as per the WHO.
